BiotechTube

ANAVEX3-71 oral capsules + Placebo oral capsules

Phase 2Active
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Schizophrenia

Conditions

Schizophrenia

Trial Timeline

Mar 15, 2024 → Jun 30, 2025

NCT ID
NCT06245213

About ANAVEX3-71 oral capsules + Placebo oral capsules

ANAVEX3-71 oral capsules + Placebo oral capsules is a phase 2 stage product being developed by Anavex Life Sciences for Schizophrenia. The current trial status is active. This product is registered under clinical trial identifier NCT06245213. Target conditions include Schizophrenia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT06245213Phase 2Active

Competing Products

20 competing products in Schizophrenia

See all competitors
ProductCompanyStageHype Score
antipsychotic dose increaseEli LillyPre-clinical
23
Olanzapine + PlaceboEli LillyPhase 3
77
Olanzapine + AripiprazoleEli LillyApproved
85
olanzapine therapyEli LillyApproved
85
olanzapine-RAIM + placeboEli LillyPhase 2
52
Clozapine + OlanzapineEli LillyApproved
85
AtomoxetineEli LillyApproved
85
Risperidone + Placebo + LY2140023Eli LillyPhase 2
52
Olanzapine + olanzapine + risperidoneEli LillyApproved
85
Zotepine + RisperidoneAstellas PharmaApproved
85
ASP4345 + Matching PlaceboAstellas PharmaPhase 1
33
ASP4345 + placebo + risperidone + quetiapine + olanzapine + ziprasidone + aripiprazole + brexpiprazole + paliperidone + lurasidoneAstellas PharmaPhase 2
52
ASP6981 + PlaceboAstellas PharmaPhase 1
33
SAPHRIS + AsenapineSun PharmaceuticalPhase 1
33
Torrent's Quetiapine Fumarate TabletsTorrent PharmaceuticalsPhase 1
33
Olanzapine HydrochlorideEli LillyPhase 1/2
41
Rapid-Acting Intramuscular Olanzapine + PlaceboEli LillyPhase 3
77
Pomaglumetad methionilEli LillyPhase 3
77
OlanzapineEli LillyApproved
85
Intramuscular Olanzapine Depot + PlaceboEli LillyPhase 3
77

Other Products from Anavex Life Sciences

ANAVEX2-73 + PlaceboPhase 3
69
ANAVEX2-73 oral liquid + Placebo oral liquidPhase 2/3
57
ANAVEX2-73Phase 2/3
57
High dose ANAVEX2-73 + Mid dose ANAVEX2-73 + Placebo oral capsulePhase 2/3
57
High dose ANAVEX2-73 + Mid dose ANAVEX2-73 + Placebo oral capsulePhase 2
44